首页> 外国专利> METHOD FOR PREDICTION OF PROGNOSIS OF SMALL CELL LUNG CANCER, METHOD FOR TREATMENT OF SMALL CELL LUNG CANCER, METHOD FOR AMELIORATION OF PROGNOSIS OF SMALL CELL LUNG CANCER, AND METHOD FOR SCREENING FOR THERAPEUTIC AGENT FOR SMALL CELL LUNG CANCER, EACH UTILIZING MIRNA

METHOD FOR PREDICTION OF PROGNOSIS OF SMALL CELL LUNG CANCER, METHOD FOR TREATMENT OF SMALL CELL LUNG CANCER, METHOD FOR AMELIORATION OF PROGNOSIS OF SMALL CELL LUNG CANCER, AND METHOD FOR SCREENING FOR THERAPEUTIC AGENT FOR SMALL CELL LUNG CANCER, EACH UTILIZING MIRNA

机译:预测小细胞肺癌预后的方法,治疗小细胞肺癌的方法,改善小细胞肺癌的预后的方法以及筛选小细胞肺癌的治疗剂的方法,每种方法均使用MIRNA

摘要

Disclosed are a method for predicting the prognosis of small cell lung cancer, a method for treating small cell lung cancer, a method for ameliorating the prognosis of small cell lung cancer, a therapeutic agent for small cell lung cancer, and a method for screening for a therapeutic agent for small cell lung cancer, each of which utilizes miRNA. Specifically disclosed are: a method for diagnosing the prognosis of a small cell lung cancer patient, which employs miR-153, miR-196a, miR-203 or miR-216a as a measure; a method for ameliorating the prognosis of small cell lung cancer, which employs the above-mentioned substance as a measure; a method for treating small cell lung cancer, which targets the above-mentioned substance; a therapeutic agent for small cell lung cancer; and a method for screening for a therapeutic agent for small cell lung cancer, which utilizes the above-mentioned substance.
机译:公开了一种预测小细胞肺癌的预后的方法,一种治疗小细胞肺癌的方法,一种改善小细胞肺癌的预后的方法,一种小细胞肺癌的治疗剂以及一种用于筛查小细胞肺癌的方法。小细胞肺癌的治疗剂,每种都利用miRNA。具体公开了:一种用于诊断小细胞肺癌患者的预后的方法,其采用miR-153,miR-196a,miR-203或miR-216a作为测量方法。以上述物质为对策的改善小细胞肺癌的预后的方法。一种针对上述物质的小细胞肺癌的治疗方法;小细胞肺癌的治疗剂;利用上述物质的小细胞肺癌治疗剂的筛选方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号